Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nefro Avillion Clinical Development, Llc

Clinical trials sponsored by Nefro Avillion Clinical Development, Llc, explained in plain language.

Not yet recruiting 1

New drug could help kidney transplant patients avoid rejection

Disease control Not yet recruiting

This study tests if a new drug called siplizumab can safely prevent kidney transplant rejection better than the current standard treatment. About 120 adults receiving a kidney transplant will be split into three groups: two groups get different doses of siplizumab, and one gets t…

Phase: PHASE2 • Sponsor: Nefro Avillion Clinical Development, LLC • Aim: Disease control

Last updated Jun 15, 2026 19:08 UTC